Exact Sciences stockholders voted to approve Abbott’s proposed acquisition, satisfying a critical vote requirement for the all-stock merger. The approval moves the transaction past a major hurdle and edges the deal closer to closing under its defined timeline.

Abbott’s board declared a quarterly common dividend of $0.63 per share, marking the company’s 409th consecutive quarterly payout. The steady dividend track reflects Abbott’s commitment to returning capital to shareholders.